A new Phase 2 clinical trial in Australia will assess whether exercise can improve the quality of life and physical function of women with recurring ovarian cancer who are on chemotherapy. Researchers at Griffith University recently were awarded a AU$884,172 grant (about $581,000) from the Medical Research Future Fund for this project. They will collaborate with teams at University of Queensland, Queensland University of Technology, Mater Hospital Brisbane, Royal Brisbane and Women’s Hospital Foundation, and the Council of…
You must be logged in to read/download the full post.
The post Phase 2 Trial to Test Exercise as Way to Improve Quality of Life in Recurring Ovarian Cancer appeared first on BioNewsFeeds.